Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Bone Marrow Transplantation|January 10, 2006
Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantationY Atsuta, R Suzuki, K Yamamoto, et al.
Bone Marrow Transplantation|April 20, 2010
A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignanciesA Takami, J L Espinoza, M Onizuka, et al.
Bone Marrow Transplantation|November 23, 2006
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantationY Inamoto, T Nishida, R Suzuki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 11, 1998
[Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation]N Hirabayashi, S Goto, Y Morishima, et al.
Bone Marrow Transplantation|August 23, 2005
Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host diseaseM Yanada, T Naoe, H Iida, et al.
Bone Marrow Transplantation|October 2, 2003
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantationM Yanada, K Yamamoto, N Emi, et al.
Bone Marrow Transplantation|November 11, 1999
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemiaY Kodera, Y Morishima, S Kato, et al.
Leukemia|July 3, 2002
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 studyJ Takeuchi, T Kyo, K Naito, et al.
Pageof 4